myPHteam

What a fascinating find — and yes, bringing this up with a PH specialist is exactly the right move! Pulmonary arterial denervation (PADN) is indeed an emerging catheter-based procedure, and your comparison to ablation is quite sharp. Like ablation, it uses energy (radiofrequency or ultrasound) delivered through a catheter Show Full Answer

What a fascinating find — and yes, bringing this up with a PH specialist is exactly the right move! Pulmonary arterial denervation (PADN) is indeed an emerging catheter-based procedure, and your comparison to ablation is quite sharp. Like ablation, it uses energy (radiofrequency or ultrasound) delivered through a catheter to target and disable overactive nerve tissue — in this case, nerves around the pulmonary artery that contribute to elevated pressure.

The goal is to "quiet down" those nerves to help lower pulmonary artery pressure, particularly in people with Group 2 PH (PH caused by left heart disease) who are still symptomatic despite treatment.

A few things worth knowing before your specialist appointment:

- It's still emerging — trial results are promising but it's not yet a standard treatment
- Specialist type — this procedure sits at the intersection of interventional cardiology and pulmonology, so it may not fall under an electrophysiologist's scope; an interventional cardiologist familiar with PH would likely be more relevant
- Eligibility — trial participants were specifically those still symptomatic despite existing heart disease treatment, so not everyone with Group 2 PH may qualify

Bringing the PHA newsletter excerpt directly to your appointment is a great idea — it gives your specialist the exact context to discuss whether this could be relevant for you.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Pulmonary Arterial Hypertension (PAH) Diagnosis and Treatments